Programmed Cell Death 4 and MicroRNA 21 Inverse Expression Is Maintained in Cells and Exosomes From Ovarian Serous Carcinoma Effusions

被引:112
|
作者
Cappellesso, Rocco [1 ]
Tinazzi, Andrea [1 ]
Giurici, Thomas [1 ]
Simonato, Francesca [1 ]
Guzzardo, Vincenza [1 ]
Ventura, Laura [2 ]
Crescenzi, Marika [3 ]
Chiarelli, Silvia [1 ]
Fassina, Ambrogio [1 ]
机构
[1] Univ Padua, Dept Med, Surg Pathol & Cytopathol Unit, I-35121 Padua, Italy
[2] Univ Padua, Dept Stat Sci, I-35121 Padua, Italy
[3] Ist Oncol Veneto IRCCS, Radiotherapy Unit, Padua, Italy
关键词
ovarian carcinoma; microRNA-21 (miR-21); programmed cell death 4 (PDCD4); exosomes; malignant effusions; NEOADJUVANT CHEMOTHERAPY; CANCER CELLS; TRANSFORMATION SUPPRESSOR; PRIMARY SURGERY; PDCD4; PROTEIN; IV; CHEMOSENSITIVITY; TRANSITION;
D O I
10.1002/cncy.21442
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Ovarian serous carcinoma (OSC) is a fatal gynecologic malignancy usually presenting with bilateral localization and malignant peritoneal effusion. Programmed cell death 4 (PDCD4) is a tumor suppressor gene whose expression is directly controlled by microRNA-21 (miR-21). Exosomes are small cell-derived vesicles that participate in intercellular communication, delivering their cargo of molecules to specific cells. Exosomes are involved in several physiological and pathological processes including oncogenesis, immunomodulation, angiogenesis, and metastasis. The current study analyzed the expression of PDCD4 and miR-21 in resected OSC specimens and in cells and exosomes from OSC peritoneal effusions. METHODS: PDCD4 was immunohistochemically examined in 14 normal ovaries, 14 serous cystadenoma (CA), and 14 OSC cases. Quantitative reverse transcriptase-polymerase chain reaction analysis of PDCD4 and miR-21 expression was performed in CA and OSC cases and in cells and exosomes obtained from 10 OSC and 10 nonneoplastic peritoneal effusions. miR-21 was also evaluated by in situ hybridization. RESULTS: Immunohistochemistry demonstrated a gradual PDCD4 loss from normal ovaries to CA and OSC specimens. Quantitative reverse transcriptase-polymerase chain reaction displayed higher PDCD4 messenger RNA levels in CA specimens compared with OSC cases and highlighted miR-21 overexpression in OSC specimens. In situ hybridization detected miR-21 only in OSC cells. This PDCD4 and miR-21 inverse expression was also noted in cells and exosomes from OSC peritoneal effusions compared with nonneoplastic effusions. CONCLUSIONS: PDCD4 and miR-21 are involved in OSC oncogenesis. The transfer of miR-21 by exosomes could promote oncogenic transformation in target cells distant from the primary tumor without direct colonization by cancer cells and could be used as a diagnostic tool. (C) 2014 American Cancer Society.
引用
收藏
页码:685 / 693
页数:9
相关论文
共 50 条
  • [31] MicroRNA-183 promotes proliferation and invasion in oesophageal squamous cell carcinoma by targeting programmed cell death 4
    L-H Ren
    W-X Chen
    S Li
    X-Y He
    Z-M Zhang
    M Li
    R-S Cao
    B Hao
    H-J Zhang
    H-Q Qiu
    R-H Shi
    British Journal of Cancer, 2014, 111 : 2003 - 2013
  • [32] MicroRNA-183 promotes proliferation and invasion in oesophageal squamous cell carcinoma by targeting programmed cell death 4
    Ren, L-H
    Chen, W-X
    Li, S.
    He, X-Y
    Zhang, Z-M
    Li, M.
    Cao, R-S
    Hao, B.
    Zhang, H-J
    Qiu, H-Q
    Shi, R-H
    BRITISH JOURNAL OF CANCER, 2014, 111 (10) : 2003 - 2013
  • [33] Downregulation of microRNA-21 expression restrains non-small cell lung cancer cell proliferation and migration through upregulation of programmed cell death 4
    Yang, Y.
    Meng, H.
    Peng, Q.
    Yang, X.
    Gan, R.
    Zhao, L.
    Chen, Z.
    Lu, J.
    Meng, Q. H.
    CANCER GENE THERAPY, 2015, 22 (01) : 23 - 29
  • [34] Downregulation of microRNA-21 expression restrains non-small cell lung cancer cell proliferation and migration through upregulation of programmed cell death 4
    Y Yang
    H Meng
    Q Peng
    X Yang
    R Gan
    L Zhao
    Z Chen
    J Lu
    Q H Meng
    Cancer Gene Therapy, 2015, 22 : 23 - 29
  • [35] MICRORNA-21 INHIBITION OF PROGRAMMED CELL DEATH4 (PDCD4) ENABLES GLIOBLASTOMA MULTIFORME PROGRESSION
    Gaur, Arti
    Colburn, Nancy
    Israel, Mark
    NEURO-ONCOLOGY, 2008, 10 (05) : 806 - 807
  • [36] Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance
    Hetland, Thea Eline
    Nymoen, Dag Andre
    Holth, Arild
    Brusegard, Kjersti
    Florenes, Vivi Ann
    Kaern, Janne
    Trope, Claes G.
    Davidson, Ben
    HUMAN PATHOLOGY, 2013, 44 (05) : 777 - 785
  • [37] The Role and Interactions of Programmed Cell Death 4 and its Regulation by microRNA in Transformed Cells of the Gastrointestinal Tract
    Ferris, William Frank
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [38] Clinical and pathological significance of programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) expression in high grade serous ovarian cancer
    Ba, Yilmaz
    Koc, Nermin
    Helvac, Kaan
    Kocak, Cem
    Akdeniz, Rasit
    Sahin, Havva Hande Keser
    TRANSLATIONAL ONCOLOGY, 2021, 14 (02):
  • [39] MicroRNA-21 Is Overexpressed in Human Cholangiocarcinoma and Regulates Programmed Cell Death 4 and Tissue Inhibitor of Metalloproteinase 3
    Selaru, Florin M.
    Olaru, Alexandru V.
    Kan, Takatsugu
    David, Stefan
    Cheng, Yulan
    Mori, Yuriko
    Yang, Jian
    Paun, Bogdan
    Jin, Zhe
    Agarwal, Rachana
    Hamilton, James P.
    Abraham, John
    Georgiades, Christos
    Alvarez, Hector
    Vivekanandan, Perumal
    Yu, Wayne
    Maitra, Anirban
    Torbenson, Michael
    Thuluvath, Paul J.
    Gores, Gregory J.
    LaRusso, Nicholas F.
    Hruban, Ralph
    Meltzer, Stephen J.
    HEPATOLOGY, 2009, 49 (05) : 1595 - 1601
  • [40] Programmed cell death 4 enhances chemosensitivity of ovarian cancer cells by activating death receptor pathway in vitro and in vivo
    Zhang, Xia
    Wang, Xiaoyan
    Song, Xingguo
    Liu, Chunmei
    Shi, Yongyu
    Wang, Yukun
    Afonja, Olubunmi
    Ma, Chunhong
    Chen, Youhai H.
    Zhang, Lining
    CANCER SCIENCE, 2010, 101 (10) : 2163 - 2170